Next Generation News and Research

RSS

Study shows engineered SARS-CoV-2 spike protein may be utilized for vaccine development

In a new study available on the preprint server bioRxiv, researchers demonstrate how the conformation of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S-protein) can be controlled with the rational construct design, providing a framework for S-protein structure engineering in vaccine/drug development.

20 May 2020

V-Sensor and e-Checkup-enabled smartphones help monitor vital signs with medical accuracy

The rapid development and deployment of mobile phone apps during the Coronavirus pandemic by governments desperate to find a way to contain the virus by using mobile device technology for tracking and tracing is a clear indicator that mass adoption of smartphones to improve health outcomes in populations is set to become mainstream.

20 May 2020

Texas A&M lab produces 3D-bioprinted bone tissue to benefit bone regeneration

Dr. Akhilesh K. Gaharwar, associate professor, has developed a highly printable bioink as a platform to generate anatomical-scale functional tissues. This study was recently published in the American Chemical Society's Applied Materials and Interfaces.

19 May 2020

New approach for real-time monitoring of calcium phosphate mineralization

Cutting-edge technology allows for real-time monitoring of biomineralization as an important process of bone formation.

19 May 2020

Novel insights on SARS-CoV-2 cell entry may inform further vaccine and treatment development

A research group from Harvard Medical School reported two cryo-electron microscopy structures derived from a single preparation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein in their paper available on the preprint server bioRxiv. Understanding the nuances of prefusion and postfusion conformations shed light on viral cell entry and may, in turn, guide the development of vaccines and drugs.

18 May 2020

Boehringer Ingelheim acquires Northern Biologics to expand cancer immunology portfolio

Boehringer Ingelheim today announced the acquisition of Northern Biologics Inc., a wholly owned subsidiary of Northern LP. By acquiring this entity, which focuses on therapeutic antibodies targeting the tumor microenvironment, Boehringer Ingelheim is now positioned at the forefront of the stromal biology space - an emerging area in cancer immunology.

From Boehringer Ingelheim International GmbH 18 May 2020

Canadian Glycomics Network welcomes $16.3 million renewed funding from NCE

The Networks of Centres of Excellence recently announced its continued support in Canadian glycomics research with a three-year investment of $16.3 million through the Canadian Glycomics Network (GlycoNet).

15 May 2020

Boehringer Ingelheim partners with CDR-Life to develop antibody fragment-based therapeutics for geographic atrophy

Boehringer Ingelheim and CDR-Life today announced they have entered into a collaboration and licensing agreement to research and develop antibody fragment-based therapeutics for geographic atrophy (GA).

From Boehringer Ingelheim International GmbH 15 May 2020

Researchers study how brain cancer cells acquire resistance to radiation

In a vertical climb to avoid collision with a towering mountain, a plane ejects cargo to gain altitude. Investigators at the University of Minnesota showed that cancer cells perform similar feats in escaping the killing effects of radiation.

14 May 2020

ACMG: Technical standard on CFTR variant testing updated

It has been nearly two decades since the American College of Medical Genetics and Genomics, together with the American College of Obstetricians and Gynecologists, made the landmark recommendation that cystic fibrosis (CF) become the first target of pan-ethnic universal carrier screening, with ACMG identifying a core panel of 23 pathogenic variants to be tested.

14 May 2020

Study provides new insights on mechanisms that promote cancer

Like subway com muters on a crowded train, cells generally prefer not to be packed in too tightly. In fact, they have set up mechanisms to avoid this, a phenomenon called "contact inhibition." A hallmark of cancer cells is that they lack this contact inhibition, and instead become pushy, facilitating their spread.

14 May 2020

Scientists to focus on personal and planetary health problems at inaugural Systems Chemistry Symposium

Nearly 1,000 international scientists from over 40 countries and six continents will gather for three days in cyberspace beginning Monday, May 18, 2020, for the inaugural Systems Chemistry Symposium, where they will explore molecular principles of living systems as models for discoveries designed to address human and planetary health challenges.

14 May 2020

Pediatric cancer patients are not at higher risk for COVID-19 infection, study finds

Researchers from MSK Kids at Memorial Sloan Kettering Cancer Center (MSK) found that children with cancer are not at a higher risk of being affected by COVID-19.

13 May 2020

Developing innovative radiation treatment for inoperable brain and spinal tumors

An innovative radiation treatment that could one day be a valuable addition to conventional radiation therapy for inoperable brain and spinal tumors is a step closer, thanks to new research led by University of Saskatchewan (USask) researchers at the Canadian Light Source (CLS).

13 May 2020

Research explores how COVID-19 is spreading and mutating in the environment

A multi-disciplinary team of experts in virology and computer modeling has quickly assembled at San Diego State University to learn more about how the new coronavirus (COVID-19) spreads in the environment and how its trajectory can be better predicted.

13 May 2020

New method to control inflammatory response induced by COVID-19

Severe COVID-19 illness can result in excessive inflammation throughout the body, including the lungs, heart and brain. University of Minnesota Twin Cities student Molly Gilligan recently published an article in the journal Cancer & Metastasis Reviews that studied the human body's robust inflammatory response to the SARS-CoV-2 virus, which is now recognized as a hallmark symptom.

13 May 2020

Study sheds more light on the evolutionary ancestry of SARS-CoV-2

There is ongoing debate among policymakers and the general public about where SARS-CoV-2, the virus that causes COVID-19, came from. While researchers consider bats the most likely natural hosts for SARS-CoV-2, the origins of the virus are still unclear.

12 May 2020

Research could aid in development of antiperspirants, treatment of sweat gland disorders

Solving sweat-related concerns that occur in daily life, such as hyperhidrosis and sweat smell, can improve people's quality of life.

9 May 2020

Scientists create German COVID-19 OMICS Initiative to accelerate research

How does the new coronavirus (SARS-CoV-2) change its genetic information? What other infections occur in patients with COVID-19? Are there genetic risk factors that favor an infection? Numerous genome researchers are pooling their expertise and sequencing infrastructure to make a scientific contribution to manage the COVID-19 pandemic.

9 May 2020

UCD researcher awarded €500,000 SFI Future Innovator Prize for innovative imaging solution

Ireland's Minister for Business, Enterprise, and Innovation, Heather Humphreys, TD, has today announced that a special Science Foundation Ireland Future Innovator Prize of €500,000 has been granted to University College Dublin researcher, Professor Dominic Zerulla.

9 May 2020

Next Generation News and Research

Study shows engineered SARS-CoV-2 spike protein may be utilized for vaccine development

V-Sensor and e-Checkup-enabled smartphones help monitor vital signs with medical accuracy

Texas A&M lab produces 3D-bioprinted bone tissue to benefit bone regeneration

New approach for real-time monitoring of calcium phosphate mineralization

Novel insights on SARS-CoV-2 cell entry may inform further vaccine and treatment development

Boehringer Ingelheim acquires Northern Biologics to expand cancer immunology portfolio

Canadian Glycomics Network welcomes $16.3 million renewed funding from NCE

Boehringer Ingelheim partners with CDR-Life to develop antibody fragment-based therapeutics for geographic atrophy

Researchers study how brain cancer cells acquire resistance to radiation

ACMG: Technical standard on CFTR variant testing updated

Study provides new insights on mechanisms that promote cancer

Scientists to focus on personal and planetary health problems at inaugural Systems Chemistry Symposium

Pediatric cancer patients are not at higher risk for COVID-19 infection, study finds

Developing innovative radiation treatment for inoperable brain and spinal tumors

Research explores how COVID-19 is spreading and mutating in the environment

New method to control inflammatory response induced by COVID-19

Study sheds more light on the evolutionary ancestry of SARS-CoV-2

Research could aid in development of antiperspirants, treatment of sweat gland disorders

Scientists create German COVID-19 OMICS Initiative to accelerate research

UCD researcher awarded €500,000 SFI Future Innovator Prize for innovative imaging solution

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News